Why the study?
Because nitric oxide (NO) is present in the dorsomedial periaqueductal gray (dmPAG), which regulates cardiovascular function, this study investigated the probable cardiovascular effects of NO in the dmPAG.
Does nitric oxide in the dorsomedial periaqueductal gray regulate cardiovascular responses in anesthetized rats?
Does nitric oxide in the dorsomedial periaqueductal gray regulate cardiovascular responses in anesthetized rats?
Nitric oxide in the dorsomedial periaqueductal gray exerts an inhibitory effect on cardiovascular responses in anesthetized rats.
Hypothesis-generating for dmPAG nitric oxide in cardiovascular control; clinical translation requires human studies before any relevance.
BACKGROUND: The dorsomedial periaqueductal gray (dmPAG) is a mesencephalic area and has numerous functions including cardiovascular regulation. Because nitric oxide (NO) is present in the dmPAG, here we investigate, the probable cardiovascular effect of NO in the dmPAG. METHODS: -nitro-L-arginine methyl ester, a NO synthase inhibitor, 90 nmol); (3) L-arginine (L-Arg, a precursor for NO, 60 nmol); (4) Sodium nitroprusside (SNP, a NO donor, 27 nmol); and (5) L-Arg + L-NAME. The cardiovascular parameters were recorded by a Power Lab device after cannulation of the femoral artery. Drugs were injected using a stereotaxic instrument. The changes (∆) in systolic blood pressure (SBP), mean arterial pressure (MAP), and heart rate (HR) were calculated at different times and compared to the control group. RESULTS: Microinjection of L-NAME significantly increased ∆SBP, ∆MAP, and ∆HR more than saline (from p < 0.05 to p < 0.001). L-Arg only significantly increased ∆HR (p < 0.05). In the L-Arg + L-NAME group, the above parameters also significantly increased (from p < 0.01 to p < 0.05) but not as significantly as with L-NAME alone. Microinjection of SNP significantly decreased ∆SBP and ∆MAP more than in the control and L-NAME groups (from p < 0.01 to p < 0.001), but ∆HR did not change significantly. CONCLUSION: The results indicated that NO in dmPAG has an inhibitory effect on cardiovascular responses in anesthetized rats.
No takes yet. Share an insight, caveat, or question.
Najaftomaraei et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: